Genpact Limited $G Shares Sold by Corient Private Wealth LP

Corient Private Wealth LP trimmed its holdings in Genpact Limited (NYSE:G - Free Report) by 76.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 74,669 shares of the business services provider's stock after selling 241,500 shares during the period. Corient Private Wealth LP's holdings in Genpact were worth $2,053,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its position in Genpact by 2.6% in the fourth quarter. Geode Capital Management LLC now owns 4,330,116 shares of the business services provider's stock valued at $210,391,000 after buying an additional 107,870 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Genpact by 12.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,609,641 shares of the business services provider's stock valued at $208,965,000 after acquiring an additional 598,877 shares during the period. Franklin Resources Inc. lifted its holdings in shares of Genpact by 3.8% in the 4th quarter. Franklin Resources Inc. now owns 3,508,847 shares of the business services provider's stock worth $164,144,000 after acquiring an additional 129,664 shares during the last quarter. First Trust Advisors LP boosted its position in shares of Genpact by 10.2% during the 1st quarter. First Trust Advisors LP now owns 2,415,994 shares of the business services provider's stock worth $89,996,000 after purchasing an additional 222,899 shares during the period. Finally, Panagora Asset Management Inc. boosted its position in shares of Genpact by 62.4% during the 4th quarter. Panagora Asset Management Inc. now owns 967,459 shares of the business services provider's stock worth $45,258,000 after purchasing an additional 371,814 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.

Analyst Upgrades and Downgrades

G has been the topic of a number of research analyst reports. Susquehanna boosted their target price on Genpact from $33.00 to $37.00 and gave the company a "neutral" rating in a research report on Friday, August 7th. Needham & Company LLC cut their price objective on Genpact from $50.00 to $45.00 and set a "buy" rating on the stock in a report on Friday, August 7th. JPMorgan Chase & Co. increased their target price on Genpact from $40.00 to $45.00 and gave the stock a "neutral" rating in a research note on Friday, August 7th. BMO Capital Markets reaffirmed a "market perform" rating and issued a $40.00 target price on shares of Genpact in a research report on Friday, August 7th. Finally, Citigroup lifted their target price on Genpact from $32.00 to $36.00 and gave the company a "neutral" rating in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $39.33.

Insider Activity

In other news, SVP Anil Nanduru sold 6,191 shares of Genpact stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total transaction of $229,252.73. Following the sale, the senior vice president owned 70,253 shares in the company, valued at approximately $2,601,468.59. The trade was a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.58% of the company's stock.

Genpact Price Performance

Shares of G opened at $33.84 on Thursday. Genpact Limited has a twelve month low of $26.85 and a twelve month high of $48.64. The firm's fifty day simple moving average is $34.92 and its 200-day simple moving average is $33.99. The firm has a market capitalization of $5.69 billion, a price-to-earnings ratio of 10.04, a PEG ratio of 0.90 and a beta of 0.58. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.44.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Tuesday, June 30th. The business services provider reported $1.00 EPS for the quarter. Genpact had a return on equity of 23.34% and a net margin of 11.04%.The firm had revenue of $1.34 billion for the quarter. Equities analysts forecast that Genpact Limited will post 3.66 EPS for the current fiscal year.

Genpact Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, September 10th will be paid a $0.1875 dividend. This represents a $0.75 annualized dividend and a yield of 2.2%. The ex-dividend date is Thursday, September 10th. Genpact's dividend payout ratio is currently 22.26%.

Genpact Company Profile

Genpact is a global professional services and technology company that helps organizations transform business processes and improve operational performance. Its services combine artificial intelligence, data and analytics, cloud technologies, digital engineering, and process expertise to support functions such as finance and accounting, procurement, supply chain management, customer care, risk management, and insurance operations.

The company serves clients across industries including banking and capital markets, insurance, healthcare and life sciences, consumer goods and retail, high technology, manufacturing, and professional services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.